BIB
Ultra Nasdaq Biotechnology
Investment Objective
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
Documents & Downloads
You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)
Performance
30 Day Daily Return
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.
Total Return
Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
---|---|---|---|---|---|---|---|---|---|---|
BIB Market Price | 0.85% | 20.64% | 17.16% | 18.70% | 29.48% | -13.61% | 8.23% | 2.44% | 16.53% | 04/07/2010 |
BIB NAV | 0.88% | 20.71% | 17.12% | 18.57% | 29.54% | -13.61% | 8.20% | 2.43% | 16.53% | 04/07/2010 |
Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
---|---|---|---|---|---|---|---|---|---|---|
BIB Market Price | 6.12% | 3.45% | 4.41% | 4.41% | 14.59% | -15.42% | 2.84% | 2.54% | 15.70% | 04/07/2010 |
BIB NAV | 6.17% | 3.43% | 4.28% | 4.28% | 14.66% | -15.37% | 2.83% | 2.53% | 15.70% | 04/07/2010 |
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.
About the Fund
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Gross Expense Ratio 1.15%
- Net Expense Ratio 0.95%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 9/26/2024- NAV $62.89
- NAV Change $+1.02
- Market Price $63.01
- Market Price Change $+1.07
- Trading Volume (M) 18,183
- 30-Day Median Bid Ask Spread 0.00%
- View Premium / Discount
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Expense Ratio 0.95%
- Gross Expense Ratio 1.15%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 9/26/2024- NAV $62.89
- NAV Change $+1.02
- Market Price $63.01
- Market Price Change $+1.07
- Trading Volume (M) 18,183
- 30-Day Median Bid Ask Spread 0.00%
- View Premium / Discount
The expense ratio above has a contractual waiver ending 9/30/24.
Exposures
Index as of 6/28/2024
Holdings
as of 9/25/2024
Exposure Weight | Ticker | Description | Exposure Value (Notional + GL) |
Market Value | Shares/Contracts | SEDOL Number |
---|---|---|---|---|---|---|
45.87% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 39,736,064 | -- | 8,465 | -- |
35.31% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 30,582,452 | -- | 6,515 | -- |
25.72% | -- | NASDAQ BIO INDEX SWAP BNP | 22,283,178 | -- | 4,747 | -- |
7.16% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 6,200,985 | -- | 1,321 | -- |
6.20% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 5,370,119 | -- | 1,144 | -- |
6.18% | GILD | GILEAD SCIENCES INC | -- | $5,351,871.00 | 65,100 | 2369174 |
5.56% | AMGN | AMGEN INC | -- | $4,819,921.16 | 15,406 | 2023607 |
5.53% | VRTX | VERTEX PHARMACEUTICALS INC | -- | $4,788,912.96 | 10,371 | 2931034 |
5.17% | REGN | REGENERON PHARMACEUTICALS | -- | $4,476,222.15 | 4,341 | 2730190 |
4.80% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 4,159,026 | -- | 886 | -- |
3.70% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC | 3,206,111 | -- | 683 | -- |
3.25% | AZN | ASTRAZENECA PLC-SPONS ADR | -- | $2,815,167.24 | 36,306 | 2989044 |
2.52% | ALNY | ALNYLAM PHARMACEUTICALS INC | -- | $2,182,930.92 | 8,004 | B00FWN1 |
1.98% | BIIB | BIOGEN INC | -- | $1,717,133.74 | 9,082 | 2455965 |
1.76% | MRNA | MODERNA INC | -- | $1,525,259.88 | 23,967 | BGSXTS3 |
1.45% | ILMN | ILLUMINA INC | -- | $1,252,921.80 | 9,932 | 2613990 |
1.27% | ARGX | ARGENX SE - ADR | -- | $1,098,569.01 | 2,001 | BDVLM39 |
1.19% | SNY | SANOFI-ADR | -- | $1,032,616.20 | 18,228 | 2964557 |
1.18% | SMMT | SUMMIT THERAPEUTICS INC | -- | $1,022,739.36 | 45,174 | BMTVQS7 |
1.15% | UTHR | UNITED THERAPEUTICS CORP | -- | $997,280.74 | 2,774 | 2430412 |
0.97% | VTRS | VIATRIS INC | -- | $838,657.05 | 74,415 | BMWS3X9 |
0.95% | BMRN | BIOMARIN PHARMACEUTICAL INC | -- | $819,267.40 | 11,870 | 2437071 |
0.91% | PCVX | VAXCYTE INC | -- | $789,568.14 | 6,959 | BKPVGH6 |
0.90% | INSM | INSMED INC | -- | $779,355.53 | 10,715 | 2614487 |
0.89% | RPRX | ROYALTY PHARMA PLC- CL A | -- | $772,568.65 | 27,941 | BMVP7Y0 |
0.88% | INCY | INCYTE CORP | -- | $759,145.76 | 12,008 | 2471950 |
0.86% | SRPT | SAREPTA THERAPEUTICS INC | -- | $740,990.52 | 5,946 | B8DPDT7 |
0.83% | NBIX | NEUROCRINE BIOSCIENCES INC | -- | $721,206.80 | 6,296 | 2623911 |
0.82% | BNTX | BIONTECH SE-ADR | -- | $707,885.40 | 6,113 | BK6H543 |
0.72% | MEDP | MEDPACE HOLDINGS INC | -- | $619,681.14 | 1,933 | BDCBC61 |
0.66% | BGNE | BEIGENE LTD-ADR | -- | $570,340.48 | 2,759 | BYYWPW6 |
0.63% | ROIV | ROIVANT SCIENCES LTD | -- | $542,691.16 | 46,108 | BMW4NZ9 |
0.61% | ASND | ASCENDIS PHARMA A/S - ADR | -- | $528,327.24 | 3,612 | BV9G6B8 |
0.57% | ITCI | INTRA-CELLULAR THERAPIES INC | -- | $489,949.56 | 6,588 | BHCB0P4 |
0.54% | RVMD | REVOLUTION MEDICINES INC | -- | $467,216.90 | 10,415 | BL71K91 |
0.54% | EXEL | EXELIXIS INC | -- | $463,477.10 | 17,785 | 2576941 |
0.51% | HALO | HALOZYME THERAPEUTICS INC | -- | $441,261.26 | 7,898 | 2975098 |
0.48% | JAZZ | JAZZ PHARMACEUTICALS PLC | -- | $415,261.00 | 3,850 | B4Q5ZN4 |
0.45% | CYTK | CYTOKINETICS INC | -- | $386,460.48 | 7,336 | BBBSBJ5 |
0.43% | IONS | IONIS PHARMACEUTICALS INC | -- | $373,664.84 | 9,116 | BDJ0LS6 |
0.43% | NUVL | NUVALENT INC-A | -- | $371,765.45 | 3,701 | BMVBZD3 |
0.40% | BPMC | BLUEPRINT MEDICINES CORP | -- | $343,650.00 | 3,950 | BWY52P3 |
0.39% | RNA | AVIDITY BIOSCIENCES INC | -- | $335,526.90 | 7,302 | BMWHPY1 |
0.38% | RARE | ULTRAGENYX PHARMACEUTICAL IN | -- | $326,142.96 | 5,746 | BJ62Z18 |
0.37% | KRYS | KRYSTAL BIOTECH INC | -- | $321,538.23 | 1,791 | BD6JX35 |
0.34% | MDGL | MADRIGAL PHARMACEUTICALS INC | -- | $292,748.34 | 1,354 | BD59BS7 |
0.33% | BBIO | BRIDGEBIO PHARMA INC | -- | $287,355.24 | 11,724 | BK1KWG8 |
0.33% | ACLX | ARCELLX INC | -- | $283,579.20 | 3,352 | BPCJ1Q2 |
0.33% | ADMA | ADMA BIOLOGICS INC | -- | $283,228.68 | 14,532 | B9NSBM2 |
0.31% | ALKS | ALKERMES PLC | -- | $271,356.81 | 10,267 | B3P6D26 |
0.31% | AXSM | AXSOME THERAPEUTICS INC | -- | $269,130.56 | 2,993 | BYZR4X4 |
0.30% | IMVT | IMMUNOVANT INC | -- | $259,360.92 | 9,126 | BJRFSB7 |
0.30% | DNLI | DENALI THERAPEUTICS INC | -- | $258,854.00 | 8,926 | BD2B4V0 |
0.29% | CRNX | CRINETICS PHARMACEUTICALS IN | -- | $251,745.50 | 4,990 | BDD19F8 |
0.28% | CRSP | CRISPR THERAPEUTICS AG | -- | $243,835.20 | 5,310 | BDHF4K6 |
0.27% | APLS | APELLIS PHARMACEUTICALS INC | -- | $232,269.87 | 7,593 | BYTQ6X1 |
0.26% | LEGN | LEGEND BIOTECH CORP-ADR | -- | $221,800.15 | 5,093 | BMX9K07 |
0.25% | DYN | DYNE THERAPEUTICS INC | -- | $218,348.80 | 6,260 | BN15WD1 |
0.24% | KYMR | KYMERA THERAPEUTICS INC | -- | $209,122.11 | 4,027 | BMPRZV5 |
0.23% | MRUS | MERUS NV | -- | $202,017.50 | 4,253 | BZBY005 |
0.23% | FOLD | AMICUS THERAPEUTICS INC | -- | $201,192.96 | 18,492 | B19FQ48 |
0.23% | RYTM | RHYTHM PHARMACEUTICALS INC | -- | $199,177.00 | 3,812 | BF2YWG4 |
0.21% | XENE | XENON PHARMACEUTICALS INC | -- | $179,795.44 | 4,724 | BRJ3GY4 |
0.20% | PTCT | PTC THERAPEUTICS INC | -- | $175,725.44 | 4,796 | B17VCN9 |
0.20% | IOVA | IOVANCE BIOTHERAPEUTICS INC | -- | $174,479.28 | 18,924 | BF0DMK7 |
0.20% | AGIO | AGIOS PHARMACEUTICALS INC | -- | $173,909.41 | 3,547 | BCBVTX1 |
0.20% | GH | GUARDANT HEALTH INC | -- | $171,041.00 | 7,670 | BFXC911 |
0.20% | GERN | GERON CORP | -- | $169,503.84 | 37,584 | 2370381 |
0.20% | PTGX | PROTAGONIST THERAPEUTICS INC | -- | $169,472.22 | 3,673 | BDCBCD8 |
0.19% | TWST | TWIST BIOSCIENCE CORP | -- | $166,832.51 | 3,653 | BGKG6G7 |
0.19% | APGE | APOGEE THERAPEUTICS INC | -- | $161,934.26 | 2,806 | BM9HHL5 |
0.18% | IDYA | IDEAYA BIOSCIENCES INC | -- | $159,958.79 | 5,267 | BK0VHF6 |
0.18% | VCYT | VERACYTE INC | -- | $159,713.15 | 4,789 | BFTWZY0 |
0.18% | ACAD | ACADIA PHARMACEUTICALS INC | -- | $158,439.44 | 10,342 | 2713317 |
0.18% | GPCR | STRUCTURE THERAPEUTICS INC | -- | $155,844.25 | 3,715 | BQS9486 |
0.18% | JANX | JANUX THERAPEUTICS INC | -- | $155,738.28 | 3,252 | BMFX8Y7 |
0.18% | IBRX | IMMUNITYBIO INC | -- | $154,603.68 | 43,428 | BNSP0B8 |
0.18% | VERA | VERA THERAPEUTICS INC | -- | $153,536.56 | 3,418 | BL55460 |
0.17% | EWTX | EDGEWISE THERAPEUTICS INC | -- | $151,261.89 | 5,847 | BKY5JZ8 |
0.17% | SWTX | SPRINGWORKS THERAPEUTICS INC | -- | $150,553.81 | 4,631 | BGMGM89 |
0.17% | ARWR | ARROWHEAD PHARMACEUTICALS IN | -- | $150,524.42 | 7,751 | BYQBFJ8 |
0.17% | MYGN | MYRIAD GENETICS INC | -- | $147,747.67 | 5,663 | 2614153 |
0.16% | AMPH | AMPHASTAR PHARMACEUTICALS IN | -- | $141,795.20 | 3,035 | BNFWZS4 |
0.16% | VCEL | VERICEL CORP | -- | $135,119.40 | 3,057 | BSBMN89 |
0.15% | HRMY | HARMONY BIOSCIENCES HOLDINGS | -- | $132,155.76 | 3,544 | BKSGZN7 |
0.15% | KROS | KEROS THERAPEUTICS INC | -- | $132,036.55 | 2,339 | BM7V485 |
0.15% | NTLA | INTELLIA THERAPEUTICS INC | -- | $131,061.44 | 6,333 | BYZM6C2 |
0.15% | VRNA | VERONA PHARMA PLC - ADR | -- | $127,141.74 | 4,499 | BYWPZK5 |
0.15% | BEAM | BEAM THERAPEUTICS INC | -- | $125,905.50 | 5,139 | BK6L288 |
0.14% | AKRO | AKERO THERAPEUTICS INC | -- | $121,212.00 | 4,329 | BK7Y2V9 |
0.14% | NVAX | NOVAVAX INC | -- | $120,183.28 | 9,982 | BJDQXG4 |
0.14% | RXRX | RECURSION PHARMACEUTICALS-A | -- | $118,163.50 | 17,150 | BM9FJ13 |
0.13% | MIRM | MIRUM PHARMACEUTICALS INC | -- | $115,956.26 | 2,974 | BJDX8Y8 |
0.13% | LGND | LIGAND PHARMACEUTICALS | -- | $112,510.42 | 1,139 | 2501578 |
0.13% | MNKD | MANNKIND CORP | -- | $109,562.94 | 17,146 | BF081J4 |
0.13% | FTRE | FORTREA HOLDINGS INC | -- | $108,815.28 | 5,586 | BRXYZ57 |
0.12% | NVCR | NOVOCURE LTD | -- | $107,614.65 | 6,747 | BYSS4X4 |
0.12% | RCKT | ROCKET PHARMACEUTICALS INC | -- | $104,760.50 | 5,675 | BDFKQ07 |
0.12% | SUPN | SUPERNUS PHARMACEUTICALS INC | -- | $102,873.84 | 3,436 | B72ZBG4 |
0.12% | ARVN | ARVINAS INC | -- | $101,264.80 | 4,280 | BDZ30Q0 |
0.11% | HROW | HARROW INC | -- | $98,345.52 | 2,212 | BHNDW86 |
0.11% | BCRX | BIOCRYST PHARMACEUTICALS INC | -- | $97,387.45 | 12,899 | 2100362 |
0.11% | SNDX | SYNDAX PHARMACEUTICALS INC | -- | $95,614.12 | 5,306 | BN7Q7R7 |
0.11% | NRIX | NURIX THERAPEUTICS INC | -- | $94,496.48 | 4,016 | BMVLGP2 |
0.11% | KURA | KURA ONCOLOGY INC | -- | $93,505.46 | 4,778 | BYZD465 |
0.10% | ARDX | ARDELYX INC | -- | $89,101.53 | 14,679 | BN89V40 |
0.10% | IRON | DISC MEDICINE INC | -- | $88,703.11 | 1,853 | BMGJZJ8 |
0.10% | DVAX | DYNAVAX TECHNOLOGIES CORP | -- | $87,990.90 | 8,170 | BRJZSK0 |
0.10% | DAWN | DAY ONE BIOPHARMACEUTICALS I | -- | $87,523.50 | 6,225 | BLB0YH0 |
0.10% | OCUL | OCULAR THERAPEUTIX INC | -- | $85,942.48 | 9,722 | BNZB1X8 |
0.10% | SPRY | ARS PHARMACEUTICALS INC | -- | $84,918.20 | 6,044 | BMCR7V2 |
0.09% | TARS | TARSUS PHARMACEUTICALS INC | -- | $76,805.36 | 2,372 | BMH5RL1 |
0.09% | XNCR | XENCOR INC | -- | $76,174.80 | 3,855 | BGCYWN8 |
0.09% | AVDL | AVADEL PHARMACEUTICALS | -- | $76,165.38 | 6,002 | BDGMC59 |
0.09% | PHAT | PHATHOM PHARMACEUTICALS INC | -- | $75,153.70 | 4,258 | BJLKVS6 |
0.09% | COLL | COLLEGIUM PHARMACEUTICAL INC | -- | $75,099.20 | 2,008 | BX7RSN3 |
0.09% | ANIP | ANI PHARMACEUTICALS INC | -- | $75,094.08 | 1,311 | BCDWBX6 |
0.09% | COGT | COGENT BIOSCIENCES INC | -- | $74,245.12 | 6,824 | BLR6XK8 |
0.09% | IMCR | IMMUNOCORE HOLDINGS PLC-ADR | -- | $73,890.60 | 2,410 | BLCD809 |
0.08% | INVA | INNOVIVA INC | -- | $73,572.86 | 3,901 | BDDXF67 |
0.08% | MRVI | MARAVAI LIFESCIENCES HLDGS-A | -- | $71,490.60 | 8,826 | BMCWKZ2 |
0.08% | ELVN | ENLIVEN THERAPEUTICS INC | -- | $71,357.35 | 2,945 | BMFD115 |
0.08% | WVE | WAVE LIFE SCIENCES LTD | -- | $70,070.77 | 7,777 | BYZG9R0 |
0.08% | TVTX | TRAVERE THERAPEUTICS INC | -- | $69,341.26 | 4,769 | BLFGJD5 |
0.08% | PRTA | PROTHENA CORP PLC | -- | $68,468.26 | 3,353 | B91XRN2 |
0.08% | CNTA | CENTESSA PHARMACEUTICALS-ADR | -- | $67,603.38 | 4,407 | BLB0YQ9 |
0.08% | ARQT | ARCUTIS BIOTHERAPEUTICS INC | -- | $66,320.80 | 7,288 | BKX9VD3 |
0.08% | GRFS | GRIFOLS SA-ADR | -- | $65,867.96 | 7,606 | B8K7T65 |
0.07% | AUPH | AURINIA PHARMACEUTICALS INC | -- | $64,188.00 | 8,915 | BFWLC09 |
0.07% | EOLS | EVOLUS INC | -- | $63,219.38 | 3,934 | BDRJH21 |
0.07% | ZLAB | ZAI LAB LTD-ADR | -- | $63,033.66 | 3,099 | BD9GVY0 |
0.07% | GMAB | GENMAB A/S -SP ADR | -- | $62,291.62 | 2,614 | BBC9WC7 |
0.07% | VIR | VIR BIOTECHNOLOGY INC | -- | $61,847.94 | 8,519 | BK4PZ38 |
0.07% | KNSA | KINIKSA PHARMACEUTICALS INTE | -- | $61,021.20 | 2,532 | BRXB0C0 |
0.07% | ANAB | ANAPTYSBIO INC | -- | $60,896.22 | 1,883 | BDRW1L7 |
0.07% | CGEM | CULLINAN THERAPEUTICS INC | -- | $59,069.10 | 3,615 | BM90J52 |
0.07% | RLAY | RELAY THERAPEUTICS INC | -- | $58,936.88 | 8,348 | BN2R582 |
0.07% | PETQ | PETIQ INC | -- | $56,856.75 | 1,849 | BDH65C8 |
0.06% | ZYME | ZYMEWORKS INC | -- | $55,419.30 | 4,430 | BPCQZY9 |
0.06% | BCYC | BICYCLE THERAPEUTICS PLC-ADR | -- | $54,031.90 | 2,314 | BKDQKM6 |
0.06% | SANA | SANA BIOTECHNOLOGY INC | -- | $52,154.96 | 13,871 | BMFJJ97 |
0.06% | TNGX | TANGO THERAPEUTICS INC | -- | $49,632.40 | 6,680 | BP2P6L0 |
0.06% | CSTL | CASTLE BIOSCIENCES INC | -- | $49,449.40 | 1,729 | BKLCWZ3 |
0.06% | ETNB | 89BIO INC | -- | $48,994.26 | 6,603 | BK1K484 |
0.06% | ERAS | ERASCA INC | -- | $48,262.36 | 17,614 | BNLYBF3 |
0.05% | REPL | REPLIMUNE GROUP INC | -- | $47,158.20 | 4,260 | BDDVW37 |
0.05% | ABUS | ARBUTUS BIOPHARMA CORP | -- | $46,020.70 | 11,770 | BZ0QMB7 |
0.05% | ABCL | ABCELLERA BIOLOGICS INC | -- | $44,827.68 | 18,372 | BL53SR3 |
0.05% | OLMA | OLEMA PHARMACEUTICALS INC | -- | $44,268.00 | 3,570 | BMZ4LN0 |
0.05% | ORIC | ORIC PHARMACEUTICALS INC | -- | $43,980.00 | 4,398 | BKVDFF7 |
0.05% | SRRK | SCHOLAR ROCK HOLDING CORP | -- | $42,963.90 | 4,990 | BFZQ0L8 |
0.05% | PLRX | PLIANT THERAPEUTICS INC | -- | $42,952.03 | 3,791 | BMDWW66 |
0.05% | AUTL | AUTOLUS THERAPEUTICS PLC | -- | $42,938.70 | 12,446 | BFMLGR4 |
0.05% | CVAC | CUREVAC NV | -- | $42,797.16 | 13,986 | BN4RD42 |
0.05% | SVRA | SAVARA INC | -- | $42,591.45 | 10,263 | BYXGN81 |
0.05% | HUMA | HUMACYTE INC | -- | $40,590.66 | 7,441 | BMYTJP4 |
0.05% | TERN | TERNS PHARMACEUTICALS INC | -- | $40,589.00 | 4,388 | BMDJ0C9 |
0.05% | PCRX | PACIRA BIOSCIENCES INC | -- | $40,005.16 | 2,876 | B3X26D8 |
0.05% | TRML | TOURMALINE BIO INC | -- | $39,975.00 | 1,599 | BQ80NC6 |
0.05% | IRWD | IRONWOOD PHARMACEUTICALS INC | -- | $39,142.80 | 9,960 | B3MZ6K5 |
0.04% | MLYS | MINERALYS THERAPEUTICS INC | -- | $36,797.00 | 3,100 | BP9N0G0 |
0.04% | ADPT | ADAPTIVE BIOTECHNOLOGIES | -- | $36,780.00 | 9,195 | BJ5FZ74 |
0.04% | FDMT | 4D MOLECULAR THERAPEUTICS IN | -- | $36,547.20 | 3,240 | BKLXFX5 |
0.04% | GLPG | GALAPAGOS NV-SPON ADR | -- | $36,074.56 | 1,264 | B292NQ7 |
0.04% | ARCT | ARCTURUS THERAPEUTICS HOLDIN | -- | $35,928.66 | 1,686 | BKC9SX3 |
0.04% | YMAB | Y-MABS THERAPEUTICS INC | -- | $35,904.68 | 2,779 | BG31GH0 |
0.04% | RVNC | REVANCE THERAPEUTICS INC | -- | $34,640.80 | 6,536 | BJFSR99 |
0.04% | THRD | THIRD HARMONIC BIO INC | -- | $34,561.38 | 2,562 | BNNPQY8 |
0.04% | ALLO | ALLOGENE THERAPEUTICS INC | -- | $34,159.56 | 13,038 | BFZNYB7 |
0.04% | LXRX | LEXICON PHARMACEUTICALS INC | -- | $34,033.89 | 22,539 | BWFZX59 |
0.04% | HCM | HUTCHMED CHINA-ADR | -- | $33,825.66 | 1,934 | BYXV9H7 |
0.04% | URGN | UROGEN PHARMA LTD | -- | $33,770.36 | 2,626 | BZ7PJQ1 |
0.04% | RGNX | REGENXBIO INC | -- | $33,367.23 | 3,081 | BZ0G875 |
0.04% | OABI | OMNIAB INC | -- | $30,867.73 | 7,367 | BN13S71 |
0.03% | SIGA | SIGA TECHNOLOGIES INC | -- | $30,037.50 | 4,450 | 2107437 |
0.03% | ALEC | ALECTOR INC | -- | $29,915.24 | 6,068 | BJ4LDC4 |
0.03% | SLRN | ACELYRIN INC | -- | $29,745.94 | 6,223 | BQPF874 |
0.03% | AVXL | ANAVEX LIFE SCIENCES CORP | -- | $28,814.15 | 5,287 | BYTYP72 |
0.03% | PAHC | PHIBRO ANIMAL HEALTH CORP-A | -- | $27,984.76 | 1,268 | BL95N25 |
0.03% | EYPT | EYEPOINT PHARMACEUTICALS INC | -- | $27,196.55 | 3,337 | BMGS7L1 |
0.03% | PACB | PACIFIC BIOSCIENCES OF CALIF | -- | $27,017.28 | 16,992 | B4N8MH9 |
0.03% | SAGE | SAGE THERAPEUTICS INC | -- | $26,718.12 | 3,806 | BP4GNK9 |
0.03% | XERS | XERIS BIOPHARMA HOLDINGS INC | -- | $26,012.00 | 9,290 | BLR7H87 |
0.03% | TSHA | TAYSHA GENE THERAPIES INC | -- | $25,683.78 | 12,778 | BNC1BX1 |
0.03% | PRME | PRIME MEDICINE INC | -- | $25,520.44 | 7,484 | BPBJFM7 |
0.03% | KALV | KALVISTA PHARMACEUTICALS INC | -- | $25,409.56 | 2,686 | BD06CS0 |
0.03% | GRAL | GRAIL INC | -- | $25,284.16 | 1,936 | BSLSSX7 |
0.03% | VERV | VERVE THERAPEUTICS INC | -- | $25,166.52 | 5,276 | BNKGXX2 |
0.03% | MXCT | MAXCYTE INC | -- | $24,963.12 | 6,552 | BKMQF66 |
0.03% | TBPH | THERAVANCE BIOPHARMA INC | -- | $24,278.00 | 3,050 | BMNDK09 |
0.03% | ITOS | ITEOS THERAPEUTICS INC | -- | $22,974.93 | 2,277 | BMWXFT4 |
0.03% | ACIU | AC IMMUNE SA | -- | $22,752.54 | 6,166 | BZC0D70 |
0.03% | NAUT | NAUTILUS BIOTECHNOLOGY INC | -- | $22,049.58 | 7,819 | BNG1NK8 |
0.02% | LYEL | LYELL IMMUNOPHARMA INC | -- | $21,548.70 | 15,962 | BN6MB18 |
0.02% | BMEA | BIOMEA FUSION INC | -- | $19,802.66 | 2,258 | BNKF6N0 |
0.02% | VYGR | VOYAGER THERAPEUTICS INC | -- | $19,618.00 | 3,400 | BY7RB53 |
0.02% | MGTX | MEIRAGTX HOLDINGS PLC | -- | $19,400.52 | 4,826 | BFYQFJ2 |
0.02% | AVIR | ATEA PHARMACEUTICALS INC | -- | $18,055.52 | 5,264 | BLN9Z50 |
0.02% | VNDA | VANDA PHARMACEUTICALS INC | -- | $17,624.90 | 3,634 | B12W3P6 |
0.02% | EDIT | EDITAS MEDICINE INC | -- | $17,431.38 | 5,142 | BZ8FPH3 |
0.02% | ZNTL | ZENTALIS PHARMACEUTICALS INC | -- | $16,671.84 | 4,434 | BMQ5T49 |
0.02% | PGEN | PRECIGEN INC | -- | $16,568.46 | 17,939 | BKM5C84 |
0.02% | EXAI | EXSCIENTIA PLC | -- | $15,954.56 | 3,104 | BP48134 |
0.02% | QURE | UNIQURE NV | -- | $14,633.52 | 3,036 | BJFSR88 |
0.02% | AMRN | AMARIN CORP PLC -ADR | -- | $14,145.52 | 24,948 | 2301938 |
0.02% | FULC | FULCRUM THERAPEUTICS INC | -- | $13,501.77 | 3,891 | BJDX8Z9 |
0.02% | AMLX | AMYLYX PHARMACEUTICALS INC | -- | $13,244.40 | 4,245 | BPCK358 |
0.01% | ATAI | ATAI LIFE SCIENCES NV | -- | $12,345.16 | 10,462 | BN6M8F1 |
0.01% | CABA | CABALETTA BIO INC | -- | $12,031.70 | 3,046 | BK5MWR1 |
0.01% | MGNX | MACROGENICS INC | -- | $11,889.44 | 3,911 | BFDV8K0 |
0.01% | CRBU | CARIBOU BIOSCIENCES INC | -- | $10,648.26 | 5,634 | BNYJR68 |
0.01% | VTYX | VENTYX BIOSCIENCES INC | -- | $10,530.34 | 4,406 | BMG99Y1 |
0.01% | CHRS | COHERUS BIOSCIENCES INC | -- | $7,117.63 | 7,183 | BRK0149 |
0.01% | ME | 23ANDME HOLDING CO -CLASS A | -- | $6,691.20 | 21,168 | BM9CKX3 |
0.01% | MRNS | MARINUS PHARMACEUTICALS INC | -- | $5,975.16 | 3,434 | BM8MVZ3 |
0.01% | ALXO | ALX ONCOLOGY HOLDINGS INC | -- | $5,944.04 | 3,284 | BLN7XQ1 |
0.01% | BLUE | BLUEBIRD BIO INC | -- | $5,672.90 | 11,868 | BBFL7S1 |
0.01% | ACRS | ACLARIS THERAPEUTICS INC | -- | $4,981.76 | 4,448 | BYV2W40 |
0.01% | OVID | OVID THERAPEUTICS INC | -- | $4,956.00 | 4,425 | BYPFK63 |
-- | RAPT | RAPT THERAPEUTICS INC | -- | $3,829.76 | 2,176 | BK5T6R0 |
-- | RPHM | RENEO PHARMACEUTICALS INC | -- | $3,188.52 | 2,084 | BMHR7T5 |
-- | 2324462D | CARTESIAN THERAPEUTICS-CVR | -- | $1,761.30 | 9,785 | BM9HFX3 |
-- | -- | TREASURY BILL | -- | $9,912,572.90 | 10,000,000 | BNNRNL0 |
-- | -- | TREASURY BILL | -- | $1,742,224.65 | 1,750,000 | BN71QC0 |
-- | -- | NET OTHER ASSETS (LIABILITIES) | -- | $13,216,831.56 | 13,216,832 | -- |
Index
as of 6/28/2024
- Total Number of Companies215
- Price/Earnings Ratio--
- Price/Book Ratio4.157
- Dividend Yield ( % )0.88
- Avg. Index Market Capitalization$7.12 billion
About the Index
The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.
Distributions
For
- 2024
- 2023
- 2022
Ex-Dividend Date | Record Date | Payable Date | Dividend | Long-Term Capital Gain | Short-Term Capital Gain | Return of Capital |
---|